Metaiodobenzylguanidine (MIBG)

DRUG2 trials

Sponsors

University of California, San Francisco, Kieuhoa Vo

Conditions

Neuroblastoma

Phase 1

High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma

CompletedNCT01313936

University of California, San FranciscoNeuroblastoma

Start: 2011-03-31End: 2014-05-31Updated: 2019-04-29

Unknown Phase

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Kieuhoa VoNeuroblastoma

Updated: 2026-07-23

Related Papers

Phase II study of <sup>131</sup>I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma.

Journal of Clinical Oncology2014-05-20